Lack of islet amyloid polypeptide/amylin-immunoreactivity in urine collected from healthy volunteers after ingestion of a carbohydrate-rich meal

Experimental and Clinical Endocrinology and Diabetes

Volumn 104, Issue 2, 1996, Pages 177-179

  Van Hulst, K L ^a,b   Nieuwenhuis, M G ^a   Hoppener J W M ^a   Lips, C J M ^a   Blankenstein, M A ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Amylin; IAPP; Islet amyloid polypeptide; Urine; cell stimulation

Indexed keywords

AMYLIN;

ADULT; ARTICLE; CARBOHYDRATE INTAKE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN EXPERIMENT; IMMUNOREACTIVITY; KIDNEY CLEARANCE; KIDNEY FAILURE; KIDNEY TUBULE ABSORPTION; NORMAL HUMAN; PANCREAS CELL; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; PROTEIN URINE LEVEL; RADIOIMMUNOASSAY; URINALYSIS;

EID: 0029874701     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1211441     Document Type: Article

References (11)

1. Cooper GJS, Willis AC, Clark A, Turner RC, Sim RB, Reid KBM: Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci USA 84: 8628-8632, 1987
2. Cooper GJS: Amylin compared with calcitonin gene-related peptide: Structure, biology, and relevance to metabolic disease. Endocr Rev 15: 163-201, 1994
3. Höppener JWM, Verbeek JS, de Koning EJP, Oosterwijk C, van Hulst KL, Visser-Vernooy HJ, Hofhuis FMA, van Gaalen S, Berends MJH, Hackeng WHL, Jansz HS, Clark A, Capel PJA, Lips CJM: Chronic overproduction of islet amyloid polypeptide/amylin in transgenic mice: Lysosomal localization of human islet amyloid polypeptide and lack of marked hyperglycaemia or hyperinsulinaemia. Diabetologia 36: 1258-1265, 1993
4. Höppener JWM, Oosterwijk C, van Hulst KL, Verbeek JS, Capel PJA, de Koning EJP, Clark A, Jansz HS, Lips CJM: Molecular physiology of the islet amyloid polypeptide (IAPP)/amylin gene in man, rat, and transgenic mice. J Cell Biochem 55S: 39-53, 1994
5. Kautzky-Willer A, Thomaseth K, Pacini G, Clodi M, Ludvik B, Streli C, Waldhäusl W, Prager R: Role of islet amyloid polypeptide secretion in insulin-resistant humans. Diabetologia 37: 188-194, 1994
6. Ludvik B, Clodi M, Kautzky-Willer A, Schuller M, Graf H, Hartter E, Pacini G, Prager R: Increased levels of circulating islet amyloid polypeptide in patients with chronic renal failure have no effect on insulin secretion. J Clin Invest 94: 2045-2050, 1994
7. 123I-labelled islet amyloid polypeptide (IAPP). Acta Oncol 32: 155-159, 1993
8. Van Hulst KL, Hackeng WHL, Höppener JWM, Van Jaarsveld BC, Nieuwenhuis MG, Blankenstein MA, Lips CJM: An improved method for the determination of islet amyloid polypeptide levels in plasma. Ann Clin Biochem 31: 165-170, 1994a
9. Van Hulst KL, Höppener JWM, Berends MJH, Nieuwenhuis MG, Blankenstein MA, Lips CJM: Characterization of antibodies against human islet amyloid polypeptide (IAPP)/amylin and its C-terminal flanking peptide (C-proIAPP). Eur J Endocrinol 130 [suppl 2]: 196, 1994b
10. Watschinger B, Hartter E, Traindl O, Pohanka E, Pidlich J, Kovarik J: Increased levels of plasma amylin in advanced renal failure. Clin Nephrol 37: 131-134, 1992
11. Westermark P, Wernstedt C, Wilander E, Hayden DW, O'Brien TD, Johnson KH: Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci USA 84: 3881-3885, 1987